There are many sub-types of NSCLC, but the three main ones are adenocarcinoma, squamous cell carcinoma and large cell ...

No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

Lung cancer remains the most frequently diagnosed cancer globally, with 2.5 million new cases, representing 12.4% of all ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific antibody) and ...

focusing on key genes linked to non-small cell lung cancer (NSCLC). Advt The study found that adenocarcinoma was the most ...

trial in patients with extensive-stage small-cell lung cancer in 2022. In July 2024, the Phase II/III SKYSCRAPER-06 ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Thursday announced positive data from INSIGHT-003 Phase I trial, evaluating the addition of Eftilagimod alpha or ...